Trial Profile
Clinical Program to Treat Individuals With Tecovirimat (ST-246) After Exposure to Orthopox Viruses
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 27 Jul 2022
Price :
$35
*
At a glance
- Drugs Tecovirimat (Primary)
- Indications Monkeypox; Orthopoxvirus infections; Vaccinia
- Focus Expanded access; Therapeutic Use
- 28 Mar 2014 New trial record